OPPENHEIMER ASSET MANAGEMENT INC. - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 191 filers reported holding IMMUNOGEN INC in Q2 2020. The put-call ratio across all filers is 1.21 and the average weighting 0.0%.

Quarter-by-quarter ownership
OPPENHEIMER ASSET MANAGEMENT INC. ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q1 2020$31,000
-38.0%
9,190
-6.2%
0.00%0.0%
Q4 2019$50,000
+100.0%
9,802
-4.0%
0.00%0.0%
Q3 2019$25,000
+4.2%
10,214
-7.0%
0.00%0.0%
Q2 2019$24,000
-20.0%
10,980
-2.4%
0.00%0.0%
Q1 2019$30,000
-44.4%
11,247
+0.3%
0.00%0.0%
Q4 2018$54,000
-52.6%
11,209
-7.0%
0.00%
-66.7%
Q3 2018$114,000
-4.2%
12,055
-1.2%
0.00%0.0%
Q2 2018$119,000
-12.5%
12,200
-5.5%
0.00%0.0%
Q1 2018$136,000
+36.0%
12,912
-1.1%
0.00%0.0%
Q4 2017$100,0000.0%13,0590.0%0.00%0.0%
Q3 2017$100,000
+12.4%
13,059
+4.4%
0.00%
+50.0%
Q2 2017$89,000
+85.4%
12,514
+0.6%
0.00%
+100.0%
Q1 2017$48,00012,4380.00%
Other shareholders
IMMUNOGEN INC shareholders Q2 2020
NameSharesValueWeighting ↓
QVT Financial LP 1,375,900$6,329,0001.08%
Redmile Group, LLC 12,006,979$55,232,0001.02%
Birchview Capital, LP 190,000$874,0000.53%
Fernwood Investment Management, LLC 179,340$825,0000.41%
HealthCor Management, L.P. 1,200,000$5,520,0000.23%
Grace Capital 49,500$228,0000.20%
TWIN FOCUS CAPITAL PARTNERS, LLC 104,068$479,0000.19%
Virtus ETF Advisers LLC 79,795$367,0000.17%
PINNACLE ASSOCIATES LTD 1,087,034$5,000,0000.12%
HUSSMAN STRATEGIC ADVISORS, INC. 100,000$460,0000.12%
View complete list of IMMUNOGEN INC shareholders